Compounding Chemotherapy Market in Global Industry: Demands, Insights, Research and Forecast 2020-2027
Compounding is the science of combining and developing drugs
that are unique to the needs of the patients. These medications are made
depending on the recommendation of the doctor in which the individual constituents
are mixed in accordance with the prescribed dose.
Global Compounding
Chemotherapy Market is expected to have a market value of USD 635.58 Million
by 2027.The trained pharmacists are permitted to modify the prescription for
the patient meeting their individual needs, including flavors, dosage
formulations, strengths, and absence of constituents for which the patient is
susceptible or allergic.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10379
Key Player
MRFR recognizes the following companies as the Key Players
in the Global Compounding Chemotherapy Market— B. Braun Melsungen AG, Pfizer
Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers
Pharmacy, Comecer S.P.A., Omnicell, Icon group, Dedalus Group, Arxium, Sterline
S.R.L., and Loccioni.
Segment Analysis
The Global Compounding Chemotherapy Market, based on dose,
has been segmented into chemotherapeutic and non-chemotherapeutics. The global
compounding chemotherapy market, by compounding type, has been segmented into
pharmaceutical ingredient alteration (PIA), currently unavailable
pharmaceutical manufacturing (CUPM), and pharmaceutical dosage alteration
(PDA). The global compounding chemotherapy market, by delivery method, has been
segmented into gravimetric automated compounding device (weight-based) and
volumetric automated compounding device (volume-based). The global compounding chemotherapy
market, by sterility, has been segmented into sterile and non-sterile. On the
basis of technology, the market has been segmented into with robotic arms and
without robotic arms. The market for the global compounding chemotherapy, by
robotic arms, is bifurcated into robots for compounding of intravenous
cytotoxic doses and non-cytotoxic dose. The global compounding chemotherapy
market, by compounder type, has been segmented into Pharmoduct, equashield pro,
medimix, integra, and others.
Regional Analysis
Global Compounding Chemotherapy Market, based on region, has
been divided into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa.
The Americas has been segmented into North America and Latin
America, with the North America market further divided into the US and Canada.
The rapid development of alternative therapies, such as oncological
chemotherapy, has been reported to offer better treatment alternatives for
breast, lung, and prostate cancer. The field of precise and personal medicine
(PPM) is expanding to deliver therapies focused on current or previous physical
fitness and environmental skills in a patient or community.
The European compounding chemotherapy market has been
further segmented into Western Europe and Eastern Europe. The Western Europe
compounding chemotherapy market has further been classified into Germany,
France, the UK, Italy, Spain, and the Rest of Western Europe. The increased use
of chemotherapy and custom medications and the growing need for mitigating
prescription errors are the main drivers of the market. Furthermore, high cost,
reluctance to implement the compounding process, and COVID-19 pandemic are
likely to have a significant effect on market growth.
The compounding chemotherapy market in Asia-Pacific has been
segmented into China, India, Japan, South Korea, Australia, and the Rest of
Asia-Pacific. Asia-Pacific is expected to register the highest growth rate
during the forecast period. This rapid growth is mainly due to the rise in
R&D financing for the healthcare sector by developing countries such as
China and India. Various other factors driving consumer development include an
increased prevalence of cancer, aging, rising demand for new treatments and
patent expiry of leading medications, regulatory efforts, as well as an
increased general understanding of various forms of cancer and possible
treatment choices.
The Middle East & Africa compounding chemotherapy market
is segmented into the Middle East and Africa. The market for compounding
chemotherapy is growing at a significant rate in the Middle East & Africa
due to the increasing number of companies and subsidiaries in the region
offering treatment options. Comecer S.p.A, an Italian biotechnology company,
generates approximately 55% of its annual sales through its specialized
radiation shielding systems used by customers in the production, handling, and
dispensing of radiopharmaceutical drugs. The company has a presence in Algeria,
the Democratic Republic of the Congo, Libya, Madagascar, Morocco, Egypt, Nigeria,
South Africa, Tunisia, Uganda, and other African countries.
Key Findings of the Study
Global Compounding Chemotherapy Market is estimated to reach
USD 58 Million by 2027 at a CAGR of 6.04% during the assessment period of 2020
to 2027
The Americas accounted for the largest share of the global
compounding chemotherapy market due to the presence of prominent players in the
US, and rapid development in therapies.
Based on dose, the chemotherapeutic segment accounted for a
larger market share of 63.0% in 2019.
On the basis of compounding type, the pharmaceutical dosage
alteration (PDA) segment to be the fastest-growing segment during the forecast
period with a CAGR of 6.45%
Based on delivery method, the volumetric automated
compounding device (volume based) segment to dominate the market with a CAGR of
7.31% during the forecast period.
Based on sterility, the non-sterile segment to be a
faster-growing segment with a CAGR of 6.17% during the review period.
Based on technology, the robotic arms segment to be a larger
and faster-growing segment with a CAGR of 6.46% during the assessment period
Based on with robotic arms, the robots for compounding of
intravenous cytotoxic doses is likely to be a larger and a faster -growing
segment with a CAGR of 6.82% during the forecast period.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/compounding-chemotherapy-market-10379
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment